Medical Director, Medical Affairs

About QED Therapeutics & BridgeBio Pharma

QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.
 
Our business is inspired by our values:

• PUT PATIENTS FIRST
• LET SCIENCE SPEAK
• EVERY MINUTE COUNTS
• THINK INDEPENDENTLY
• BE RADICALLY TRANSPARENT

FGFR=fibroblast growth factor receptor.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://www.qedtx.com/ | https://bridgebio.com 

Who You Are

Reporting to the Head of Medical Affairs, The Medical Director, Medical Affairs will play an essential role in the planning, implementation, and daily operation of the medical affairs’ pre-launch and peri-launch activities of infigratinib for achondroplasia and hypochondroplasia. This individual is ultimately responsible for supporting the successful launch of infigratinib for achondroplasia and hypochondroplasia. The Medical Director will collaborate with key internal and external stakeholders to lead medical affairs aspects of our achondroplasia and hypochondroplasia programs, contributing their functional area and scientific knowledge. They are responsible for providing medical leadership or support to infigratinib’s medical affairs strategy and tactics. These tactics will include, among others, implementation of post marketing commitments, medical review (MLR), congress planning and attendance, advisory board meetings preparation and conduct, Investigator Sponsored Trials review. 

Responsibilities

• Develop medical content to educate HCPs, advocates and internal stakeholders on achondroplasia, hypochondroplasia and infigratinib
• Lead or co-lead advisory board meetings and symposia to support infigratinib
•  Responsible for engagement with clinical consultants, Key Opinion Leaders (KOLs) and the research community to support the company’s initiatives
•  Responsible for developing a training curriculum for new hires or new team members, MSLs, sales and marketing colleagues and other internal colleagues
• Medical reviewer and approver for Medical and Commercial content as the Medical Affairs representative at BrideBio’s MLR (Medical, Legal and Regulatory Review Committee) for achondroplasia, hypochondroplasia and infigratinib
•  Collaborate with HEOR in health economics and burden of disease initiatives
•  Co-develop Field Medical strategy and tactics in partnership with the Field Medical/MSL Team
•  Collaborate with clinical development on ongoing and planned clinical trials (phase 2-4)
• Collaborate with clinical development and other cross-functional teams to establish scientific data dissemination strategies to support registration and launch activities
•  Support patient advocacy team in development and review of patient and advocacy initiatives
• Represent company at scientific, clinical, and professional organizations meetings
• Collaborate with Scientific Communications to prepare publications and presentations for external meetings
•  Function as the medical representative at cross-functional and project teams meetings
•  This is an individual contributor role with high visibility internally and externally
•  This role is remote but US-based and has no direct reports
•  The focus of the role is the USA and will have interactions with international colleagues
• Additional responsibilities as needed

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• MD, PhD, or PharmD with 3 or more years of post-graduate experience
• At least 3 years (or more) of post-graduate US medical affairs experience in a pharmaceutical or biotechnology company are needed
• Experience in rare diseases is a plus
• Experience in endocrinology or pediatric endocrinology is desired
• Clinical and patient management experience is a plus
• Strong interpersonal and leadership skills are needed
• Solid understanding of the process of pharmaceutical product development and approval is needed
• Experience at successfully launching a biopharmaceutical asset in the USA is a must
• Experience in medical affairs strategy and development of medical affairs plans is necessary
• Demonstrated ability to effectively execute medical affairs tactics on time and budget is needed
• Understanding US payor and reimbursement landscape is desired
• Knowledge of US regulations impacting Medical Affairs and Field Medical activities in the pharmaceutical industry is critical
• Demonstrated ability to organize, prioritize, and execute work in a fast-paced environment with minimal supervision is needed
• Excellent written and verbal communication skills
• Ability to travel domestically and internationally, up to 40% of the time to attend scientific meetings, advisory boards, and other venues as needed. Travel will include overnight stays and weekend work based upon business needs
• Team player who effectively collaborates with people of diverse educational, cultural and professional backgrounds
• Consensus seeker who knows how to lead and contribute without direct authority 

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion